011000.KS

GeneOne Life Science, Inc. [011000.KS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

011000.KS Stock Summary

Top 10 Correlated Stocks

011000.KS


011000.KS Financial details

Company Rating
Buy
Market Cap
537.63B
Income
-25.84B
Revenue
49.07B
Book val./share
3070.07
Cash/share
-
Dividend
-
Dividend %
-
Employees
61
Optionable
No
Shortable
Yes
Earnings
-
P/E
-18.85
Forward P/E
-
PEG
-4.25
P/S
9.92
P/B
2.26
P/C
-
P/FCF
-5.18
Quick Ratio
-
Current Ratio
2.85
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-368.25
EPS next Y
-
EPS next Q
-
EPS this Y
-14.51%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-20.57%
Revenue last 5Y
7.33%
Revenue Q/Q
-12.79%
EPS Q/Q
-27.97%
-
-
-
-
SMA20
-9.8%
SMA50
-32.76%
SMA100
-32.82%
Inst Own
-
Inst Trans
-
ROA
-10%
ROE
-12%
ROC
-0.15%
Gross Margin
27%
Oper. Margin
-67%
Profit Margin
-53%
Payout
-
Shs Outstand
77.47M
Shs Float
70.54M
-
-
-
-
Target Price
-
52W Range
6480.0-23450.0
52W High
-70.41%
52W Low
+7.1%
RSI
37
Rel Volume
0.41
Avg Volume
766.36K
Volume
310.6K
Perf Week
-5.58%
Perf Month
-26.87%
Perf Quarter
-38.58%
Perf Half Y
-44.48%
-
-
-
-
Beta
-1.83914
-
-
Volatility
239.21%, 754.34%
Prev Close
-1%
Price
6940
Change
-1.84%

011000.KS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
790.37847.921.13K567.53529.21
Net income per share
-690.26-294.18-208.97-255.01-218.13
Operating cash flow per share
-117.52-179.73-34.84-217.64-66.31
Free cash flow per share
-129.52-269.79-117.39-441.49-1.19K
Cash per share
658.83561.09479.381.24K1.47K
Book value per share
1.06K727.2659.961.35K2.81K
Tangible book value per share
946.96714.24644.081.34K2.8K
Share holders equity per share
1.06K727.2659.961.35K2.81K
Interest debt per share
95.96340.7451.33251.54312.53
Market cap
129.06B110.88B127.36B780.24B899.48B
Enterprise value
118.49B114.89B124.92B735.57B895.57B
P/E ratio
-5.44-9.32-16.72-41.84-56.39
Price to sales ratio
4.753.233.0918.823.24
POCF ratio
-31.95-15.25-100.28-49.02-185.49
PFCF ratio
-28.99-10.16-29.76-24.17-10.3
P/B Ratio
3.533.775.297.924.38
PTB ratio
3.533.775.297.924.38
EV to sales
4.363.353.0317.7223.14
Enterprise value over EBITDA
-5.83-12.69-71.1-54.18-137.14
EV to operating cash flow
-29.33-15.81-98.37-46.22-184.69
EV to free cash flow
-26.61-10.53-29.19-22.78-10.25
Earnings yield
-0.18-0.11-0.06-0.02-0.02
Free cash flow yield
-0.03-0.1-0.03-0.04-0.1
Debt to equity
000.080.010.03
Debt to assets
0.20.40.530.280.18
Net debt to EBITDA
0.52-0.441.393.290.6
Current ratio
4.042.031.622.963.87
Interest coverage
-13.49-8.09-4.17-29.37-6.17
Income quality
0.170.610.170.850.3
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.030.020.020.010.02
Research and developement to revenue
0.310.170.140.20.3
Intangibles to total assets
0.090.010.010.010
Capex to operating cash flow
0.10.52.371.0317.02
Capex to revenue
-0.02-0.11-0.07-0.39-2.13
Capex to depreciation
-0.37-2.82-0.88-4.07-17.82
Stock based compensation to revenue
0.310.06000
Graham number
4.06K2.19K1.76K2.78K3.71K
ROIC
-0.67-0.37-0.29-0.18-0.13
Return on tangible assets
-0.57-0.24-0.15-0.14-0.06
Graham Net
494.31166.18-143.8774.06939.53
Working capital
26.08B19.37B13.94B72.06B98.71B
Tangible asset value
32.55B28.89B23.48B97.83B204.81B
Net current asset value
25.56B18.3B9.5B70.7B89.12B
Invested capital
0.040.420.60.180.09
Average receivables
00000
Average payables
4.59B4.21B4.59B6.88B12.21B
Average inventory
7.59B8.06B8.52B8.3B9.49B
Days sales outstanding
00000
Days payables outstanding
38.8623.8129.5483.47213.69
Days of inventory on hand
116.65121.09112.59100.67130.28
Receivables turnover
00000
Payables turnover
9.3915.3312.364.371.71
Inventory turnover
3.133.013.243.632.8
ROE
-0.65-0.4-0.32-0.19-0.08
Capex per share
-12-90.06-82.55-223.85-1.13K

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q3

Metric History 2021-09-302021-12-312022-03-312022-06-30 2022-09-30
Revenue per share
92.86145.4170.13205.1178.85
Net income per share
-78.41-33.3-65.88-156.41-112.66
Operating cash flow per share
10.9452.26-127.68-13.4-78.96
Free cash flow per share
-334.79-452.37-350.76-202.58-183.09
Cash per share
523.531.53K000
Book value per share
1.3K2.93K2.89K2.94K3.07K
Tangible book value per share
1.29K2.92K2.89K2.94K3.07K
Share holders equity per share
1.3K2.93K2.89K2.94K3.07K
Interest debt per share
401.93282.56-1.983.11-24.42
Market cap
1546.68B1136.55B1048.86B722.62B667.9B
Enterprise value
1537.03B1132.64B1048.86B722.62B667.9B
P/E ratio
-70.29-121.63-56.73-16.46-21.12
Price to sales ratio
237.4111.4287.8750.2253.23
POCF ratio
2.02K310-117.09-768.82-120.56
PFCF ratio
-65.85-35.81-42.62-50.84-52
P/B Ratio
16.965.535.173.53.1
PTB ratio
16.965.535.173.53.1
EV to sales
235.92111.0387.8750.2253.23
Enterprise value over EBITDA
-507.641.7K-311.57-67.32-69.45
EV to operating cash flow
2K308.93-117.09-768.82-120.56
EV to free cash flow
-65.44-35.69-42.62-50.84-52
Earnings yield
000-0.02-0.01
Free cash flow yield
-0.02-0.03-0.02-0.02-0.02
Debt to equity
0.090.03000
Debt to assets
0.350.180.170.180.17
Net debt to EBITDA
3.19-5.88000
Current ratio
1.483.873.482.982.85
Interest coverage
-7.06-6.7448.79-434.22
Income quality
-0.14-1.571.940.090.7
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.030.020.861.080.74
Research and developement to revenue
0.40.38000
Intangibles to total assets
00000
Capex to operating cash flow
-31.61-9.661.7514.121.32
Capex to revenue
-3.72-3.47-1.31-0.92-0.58
Capex to depreciation
-18.82-28.39-11.29-9.67-5.16
Stock based compensation to revenue
00000
Graham number
1.51K1.48K2.07K3.22K2.79K
ROIC
-0.09-0.04-0.03-0.04-0.03
Return on tangible assets
-0.04-0.01-0.02-0.04-0.03
Graham Net
-89.4979.32-603.91-655.05-634.47
Working capital
18.85B98.71B80.51B70.24B61.98B
Tangible asset value
90.53B204.81B000
Net current asset value
10.08B89.12B70.55B59.73B51B
Invested capital
0.30.09000
Average receivables
00000
Average payables
00000
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
190.28176.61000
Days of inventory on hand
158.2107.67000
Receivables turnover
00000
Payables turnover
0.470.51000
Inventory turnover
0.570.84000
ROE
-0.06-0.01-0.02-0.05-0.04
Capex per share
-345.73-504.63-223.08-189.19-104.12

011000.KS Frequently Asked Questions

What is GeneOne Life Science, Inc. stock symbol ?

GeneOne Life Science, Inc. is a US stock and trading under the symbol 011000.KS

What is GeneOne Life Science, Inc. stock quote today ?

GeneOne Life Science, Inc. stock price is $6940 today.

Is GeneOne Life Science, Inc. stock public?

Yes, GeneOne Life Science, Inc. is a publicly traded company.

Something similar

Same Sector
Top Correlated Stocks
Similar Market Cap